Search for: "v. Teva Pharmaceuticals USA, Inc." Results 341 - 360 of 441
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
14 Mar 2014, 8:00 am by John Elwood
  First up is Teva Pharmaceuticals USA, Inc. v. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
6 Apr 2011, 12:18 am by Marie Louise
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
14 Jun 2011, 12:21 pm by John Elwood
Teva Pharmaceuticals USA, Inc., 10-1070, in which the Court had relisted twice and called for a response. [read post]
30 May 2012, 8:28 am by Michelle Yeary
Teva Pharmaceuticals USA, Inc., 2012 U.S. [read post]
22 Jan 2015, 6:24 am by assoulineberlowe
In a recent decision, the Supreme Court of the United States held in Teva Pharmaceuticals USA, Inc., et al. v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]